DSIP (Delta Sleep-Inducing Peptide)

How DSIP Was Discovered

UKPWritten and published by UK Peptides2 min readUpdated 3 cited sources

The short answer

The Schoenenberger-Monnier group in Basel electrically stimulated the thalamus of a sleeping rabbit, collected cerebral venous blood draining from the brain, and isolated a peptide fraction from it. Administered to awake rabbits it was reported to produce delta-wave EEG activity. Published in PNAS, March 1977.

Key facts

Group
Schoenenberger-Monnier, Basel
Isolation published
PNAS, March 1977 (PMID 265572)
Sequence published
Pflügers Arch, 1978 (PMID 568769)
Source material
Rabbit cerebral venous blood
Induction method
Electrical thalamic stimulation
Assay route
Intraventricular administration
Endpoint
Delta-wave EEG activity

The reasoning behind the experiment

The design rests on a specific hypothesis: that sleep is induced by a circulating humoral factor. If so, blood leaving the brain of a sleeping animal should carry more of it than blood leaving an awake one, and transferring that blood should transfer the state. This is a coherent idea with a long history in physiology, and the experiment is a direct test of it.

How it was done

The thalamus of a rabbit was electrically stimulated to induce sleep. Blood draining from the brain was collected. Cerebral venous blood specifically, because the point was to capture what the brain had released rather than what was arriving. A peptide fraction was isolated from that blood and administered into the cerebral ventricles of awake rabbits, where it was reported to produce the slow delta-wave EEG pattern of deep sleep.

Research material referenced

DSIP 5mg, third-party HPLC tested

Buy DSIP · £13.95

Then the sequence

The 1978 paper in Pflügers Archiv reported amino-acid analysis, sequence determination, synthesis and activity of the nonapeptide: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Synthesising the peptide and reproducing the activity was the correct next step, and it is what elevated DSIP from an uncharacterised fraction to a defined molecule.

What the method could not rule out

Cerebral venous blood contains a great deal besides any putative sleep factor. Isolating a peptide fraction that produces an EEG change does not establish that the peptide is what the brain releases to produce sleep, nor that it acts through a physiological pathway rather than a pharmacological one at the concentrations delivered. Intraventricular administration in particular bypasses every normal barrier and delivers to a compartment endogenous signalling may never reach at that concentration.

Judging it fairly

By the standards of 1977 this was careful, imaginative work, and the group followed isolation with sequencing and synthesis rather than stopping at a suggestive fraction. The problem is not the original research. It is that the field never completed the steps that would have converted a promising observation into established biology, and the name has carried an unearned confidence in the meantime.

Frequently asked questions

Why rabbits?

Rabbits were a standard model for sleep and EEG work of the period, and their size permits collection of cerebral venous blood.

Was the peptide synthesised and retested?

Yes. The 1978 Pflügers Archiv paper reported sequence, synthesis and activity of the synthetic nonapeptide, which was the right way to confirm the isolated fraction.

Does intraventricular administration reflect normal physiology?

Not closely. It bypasses the blood-brain barrier and delivers directly to a compartment, at concentrations endogenous signalling may never produce.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More DSIP (Delta Sleep-Inducing Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.